Cooper Ronald Harold Wilfred
- SEC CIK
- 0001676880
No open-market purchases or sales filed in the past year.
Current role at each company
- CCCC C4 Therapeutics, Inc.Directoras of Jun 26, 2026
- GBIO Generation Bio Co.Directoras of Feb 9, 2026
- ENGN enGene Therapeutics Inc.CEO & Presidentas of Feb 3, 2026
- ALBO Albireo Pharma, Inc.President and CEOas of Mar 2, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Cooper Ronald Harold Wilfred as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ENGN enGene Therapeutics Inc.
CEO & President1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 2024 (view filing) | Sep 27 | 4 days | Cooper Ronald Harold WilfredChief Executive Officer | PPurchase | +10.0K | $5.70 | +$57.0K | New position10.0K after |
ALBO Albireo Pharma, Inc.
President and CEO5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 23, 2023 (view filing) | Jan 23 | Same day | Cooper Ronald Harold WilfredPresident and CEO | SSale | −1.06K | $43.80 | −$46.3K | −1.8%57.4K after | |
| Jan 9, 2023 (view filing) | Oct 24, 2022 | 77 days | Cooper Ronald Harold WilfredPresident and CEO | SSale | −919 | $19.58 | −$18.0K | −1.5%58.5K after | Amended |
| Jul 25, 2022 (view filing) | Jul 22 | 3 days | Cooper Ronald Harold WilfredPresident and CEO | SSale | −929 | $24.67 | −$22.9K | −1.6%56.4K after | |
| Apr 25, 2022 (view filing) | Apr 22 | 3 days | Cooper Ronald Harold WilfredPresident and CEO | SSale | −907 | $33.11 | −$30.0K | −1.6%56.1K after | |
| Jan 25, 2022 (view filing) | Jan 24 | 1 day | Cooper Ronald Harold WilfredPresident and CEO | SSale | −3.68K | $24.88 | −$91.7K | −6.1%57.0K after |